Cáncer de mama inflamatorio

Five-year relative survival rates for women with inflammatory breast cancer are 53% when the cancer has spread to nearby lymph nodes or tissues and 22% when it has spread to distant parts of the body. These categories are called regional disease and distant disease in survival statistics. Regional disease generally corresponds to stage 3 inflammatory breast cancer. Distant disease corresponds to stage 4. Survival statistics do not include a localized category for inflammatory breast cancer because the cancer already involves the breast skin when it is diagnosed.

Survival statistics

A five-year relative survival rate compares people with the same type and extent of cancer with people in the overall population. For example, a 53% five-year relative survival rate means that people with regional inflammatory breast cancer are about 53% as likely as people without that cancer to be alive five years after diagnosis.

It's important to remember that survival rates describe groups of people treated in the past. They cannot predict exactly what will happen for one person in the future. Your healthcare team can explain what these survival statistics may mean for you.

The available five-year relative survival rates are:

• 53% for regional inflammatory breast cancer, meaning cancer that has spread beyond the breast to nearby lymph nodes or structures.
• 22% for distant inflammatory breast cancer, meaning cancer that has spread to a distant part of the body.
• 40% for all stages combined.

Inflammatory breast cancer is serious because it grows and spreads quickly and is often diagnosed at an advanced stage. Stage 3 inflammatory breast cancer may be treated with the goal of removing all the cancer and preventing it from returning. Stage 4 inflammatory breast cancer generally is not considered curable, but treatment may slow its growth and help people live longer. Treatment focuses on managing the cancer, easing symptoms and maintaining quality of life.

What you can do

Factors that can affect prognosis include the cancer's stage, hormone receptor and HER2 status, overall health, how well treatment works, and whether the cancer returns after treatment. Following the treatment plan and keeping follow-up appointments help the care team assess the cancer's response, manage side effects and watch for recurrence. Ask your healthcare team what the statistics may mean in your situation and whether a clinical trial may be an option.

Treatment can affect daily life and quality of life. Supportive and palliative care can help manage symptoms and treatment effects. Ongoing research and newer treatments may improve outcomes beyond those reflected in older survival data.

Breast Cancer Discussions

What age is too old for breast reconstruction?

21 Replies Wed, Aug 19, 2026

Has anyone changed from Anastrozole to Exemestane?

42 Replies Tue, Aug 18, 2026

Signatera Test. Is it truly helpful and worthwhile?

129 Replies Mon, Aug 17, 2026